SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 2)*
West Pharmaceutical Services Inc.
-------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
-------------------------------------------------------------------------------
(Title of Class of Securities)
955306-105
-------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2003
-------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[X] Rule 13d-1(b)
[_] Rule 13d-(c)
[_] Rule 13d-1(d)
----------
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 955306-105
-------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Wilmington Trust Corporation
-------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [_]
-------------------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware corporation
-------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER 439,620
SHARES _____________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER 450,298
OWNED BY _____________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER 439,620
REPORTING _____________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER 450,298
WITH:
-------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
889,918
-------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [_] N/A
-------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.1%
-------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
HC
-------------------------------------------------------------------------------
CUSIP No. 955306-105
_______________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Wilmington Trust Company
-------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [_]
-------------------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware banking corporation
-------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER 439,620
SHARES _____________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER 445,400
OWNED BY _____________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER 439,620
REPORTING _____________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER 445,400
WITH:
-------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
885,020
-------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [_] N/A
-------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.1%
-------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
BK
CUSIP No. 955306-105
-------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Wilmington Trust FSB
-------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [_]
-------------------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Federal Savings Bank
-------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER 0
SHARES _____________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER 4,898
OWNED BY _____________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER 0
REPORTING _____________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER 4,898
WITH:
-------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,898
-------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [_] N/A
-------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0%
-------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
BK
-------------------------------------------------------------------------------
CUSIP No. 955306-105
------------------------------------------------------------------------------
Item 1(a). Name of Issuer:
West Pharmaceutical Services Inc.
------------------------------------------------------------------------------
Item 1(b). Address of Issuer's Principal Executive Offices:
101 Gordon Drive
Lionville, PA 19341-0645
-----------------------------------------------------------------------------
Item 2(a). Name of Person Filing:
Wilmington Trust Corporation, Wilmington Trust Company
and Wilmington Trust FSB
------------------------------------------------------------------------------
Item 2(b). Address of Principal Business Office, or if None, Residence:
1100 North Market Street
Wilmington, DE 19890
------------------------------------------------------------------------------
Item 2(c). Citizenship:
Wilmington Trust Corporation is a Delaware corporation;
Wilmington Trust Company is a Delaware banking corporation; and
Wilmington Trust FSB is a Federal Savings Bank.
------------------------------------------------------------------------------
Item 2(d). Title of Class of Securities:
Common Stock
------------------------------------------------------------------------------
Item 2(e). CUSIP Number:
955306-105
------------------------------------------------------------------------------
Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or
(c), Check Whether the Person Filing is a:
(a) [_] Broker or dealer registered under Section 15 of the Exchange Act.
(b) [X] Bank as defined in Section 3(a)(6) of the Exchange Act.
CUSIP No. 955306-105
Wilmington Trust Company and Wilmington FSB are each Banks and
are each direct, wholly- owned subsidiaries of Wilmington Trust
Corporation.
(c) [_] Insurance company as defined in Section 3(a)(19) of the Exchange
Act.
(d) [_] Investment company registered under Section 8 of the Investment
Company Act.
(e) [_] An investment adviser in accordance with Rule
13d-1(b)(1)(ii)(E);
(f) [_] An employee benefit plan or endowment fund in accordance with
Rule 13d-1(b)(1)(ii)(F);
(g) [X] A parent holding company or control person in accordance with
Rule 13d-1(b)(1)(ii)(G);
Wilmington Trust Corporation is a Parent Holding Company.
(h) [_] A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act;
(i) [_] A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment Company
Act;
(j) [X] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
Wilmington Trust Corporation, Wilmington Trust Company and
Wilmington Trust FSB are a Group.
Item 4. Ownership.
Provide the following information regarding the aggregate number and percentage
of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned:
Wilmington Trust Corporation: 889,918 shares
Wilmington Trust Company: 885,020 shares
Wilmington Trust FSB: 4,898 shares
(b) Percent of class:
Wilmington Trust Corporation: 6.1%
CUSIP No. 955306-105
Wilmington Trust Company: 6.1%
Wilmington Trust FSB: 0%
(c) Number of shares as to which Wilmington Trust Corporation has:
(i) Sole power to vote or to direct the vote 439,620 shares
(ii) Shared power to vote or to direct the vote 450,298 shares
(iii) Sole power to dispose or to direct the disposition of 439,620
shares
(iv) Shared power to dispose or to direct the disposition of 450,298
shares
Number of shares as to which Wilmington Trust Company has:
(i) Sole power to vote or to direct the vote 439,620 shares
(ii) Shared power to vote or to direct the vote 445,400 shares
(iii) Sole power to dispose or to direct the disposition of 439,620
shares
(iv) Shared power to dispose or to direct the disposition of 445,400
shares
Number of shares as to which Wilmington Trust FSB has:
(i) Sole power to vote or to direct the vote 0 shares
(ii) Shared power to vote or to direct the vote 4,898 shares
(iii) Sole power to dispose or to direct the disposition of 0 shares
(iv) Shared power to dispose or to direct the disposition of 4,898
shares
------------------------------------------------------------------------------
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following [ ]
------------------------------------------------------------------------------
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
Not applicable.
------------------------------------------------------------------------------
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company.
Wilmington Trust Company: BK
Wilmington Trust FSB: BK
CUSIP No. 955306-105
------------------------------------------------------------------------------
Item 8. Identification and Classification of Members of the Group.
Wilmington Trust Corporation: HC
Wilmington Trust Company: BK
Wilmington Trust FSB: BK
------------------------------------------------------------------------------
Item 9. Notice of Dissolution of Group.
Not applicable.
------------------------------------------------------------------------------
Item 10. Certifications.
By signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were acquired and are held in the ordinary course
of business and were not acquired and are not held for the purpose of or with
the effect of changing or influencing the control of the issuer of the
securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
February 3, 2004
By: s/Michael A. DiGregorio
-------------------------
Michael A. DiGregorio
Senior Vice President
WILMINGTON TRUST CORPORATION
WILMINGTON TRUST COMPANY
WILMINGTON TRUST FSB
Note. Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
Attention. Intentional misstatements or omissions of fact constitute federal
criminal violations (see 18 U.S.C. 1001).
WILMINGTON TRUST COMPANY
1100 North Market Street
Wilmington, Delaware 19890
February 3, 2004
United States Securities and
Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Dear Gentlemen/Ladies:
Pursuant to Rule 13d-1(b)(1) under the Securities Exchange Act of 1934, as
amended, we are filing herewith in electronic format a Schedule 13-G reflecting
beneficial ownership as of December 31, 2003 by Wilmington Trust Company, with
respect to the following issuer and security:
West Pharmaceutical Services Common Stock
Please contact me if there are any questions regarding this filing.
Sincerely,
/s/ Sharon L. Corbett
----------------------------
Sharon L. Corbett
Assistant Vice President and
Fiduciary Compliance Counsel
Telephone Number (302) 651-8378